78 related articles for article (PubMed ID: 24354546)
21. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
Cicero TJ; Inciardi JA; Muñoz A
J Pain; 2005 Oct; 6(10):662-72. PubMed ID: 16202959
[TBL] [Abstract][Full Text] [Related]
22. Substance use histories in patients seeking treatment for controlled-release oxycodone dependence.
Potter JS; Hennessy G; Borrow JA; Greenfield SF; Weiss RD
Drug Alcohol Depend; 2004 Nov; 76(2):213-5. PubMed ID: 15488345
[TBL] [Abstract][Full Text] [Related]
23. Differences in prevalence of prescription opiate misuse among rural and urban probationers.
Havens JR; Oser CB; Leukefeld CG; Webster JM; Martin SS; O'Connell DJ; Surratt HL; Inciardi JA
Am J Drug Alcohol Abuse; 2007; 33(2):309-17. PubMed ID: 17497554
[TBL] [Abstract][Full Text] [Related]
24. Nonmedical drug use among stimulant-using adults in small towns in rural Ohio.
Falck RS; Siegal HA; Wang J; Carlson RG; Draus PJ
J Subst Abuse Treat; 2005 Jun; 28(4):341-9. PubMed ID: 15925268
[TBL] [Abstract][Full Text] [Related]
25. Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users.
Darredeau C; Barrett SP; Jardin B; Pihl RO
Hum Psychopharmacol; 2007 Dec; 22(8):529-36. PubMed ID: 17910020
[TBL] [Abstract][Full Text] [Related]
26. OxyContin abuse and diversion and efforts to address the problem: highlights of a government report.
Government Accounting Office
J Pain Palliat Care Pharmacother; 2004; 18(3):109-13. PubMed ID: 15364638
[TBL] [Abstract][Full Text] [Related]
27. Assessing subjective and physiologic effects following intranasal administration of a new formulation of immediate release oxycodone HCl (Oxecta™) tablets in nondependent recreational opioid users.
Schoedel KA; Rolleri RL; Faulknor JY; Pixton GC; Chen N; Bass A; Sommerville KW; Sellers E
J Opioid Manag; 2012; 8(5):315-27. PubMed ID: 23247908
[TBL] [Abstract][Full Text] [Related]
28. The OxyContin crisis: problematisation and responsibilisation strategies in addiction, pain, and general medicine journals.
Whelan E; Asbridge M
Int J Drug Policy; 2013 Sep; 24(5):402-11. PubMed ID: 23452867
[TBL] [Abstract][Full Text] [Related]
29. The danger of imperfect regulation: OxyContin use in the United States and Canada.
Lexchin J; Kohler JC
Int J Risk Saf Med; 2011; 23(4):233-40. PubMed ID: 22156088
[TBL] [Abstract][Full Text] [Related]
30. The abuse potential of Remoxy(®), an extended-release formulation of oxycodone, compared with immediate- and extended-release oxycodone.
Setnik B; Roland CL; Cleveland JM; Webster L
Pain Med; 2011 Apr; 12(4):618-31. PubMed ID: 21463474
[TBL] [Abstract][Full Text] [Related]
31. 'Opioid drought', Canadian-style? Potential implications of the 'natural experiment' of delisting oxycontin in Canada.
Fischer B; Keates A
Int J Drug Policy; 2012 Nov; 23(6):495-7. PubMed ID: 22940141
[No Abstract] [Full Text] [Related]
32. Ephemeral profiles of prescription drug and formulation tampering: evolving pseudoscience on the Internet.
Cone EJ
Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S31-9. PubMed ID: 16458455
[TBL] [Abstract][Full Text] [Related]
33. Effect of abuse-deterrent formulation of OxyContin.
Cicero TJ; Ellis MS; Surratt HL
N Engl J Med; 2012 Jul; 367(2):187-9. PubMed ID: 22784140
[No Abstract] [Full Text] [Related]
34. The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?
Kaye S; Darke S
Addiction; 2012 Mar; 107(3):467-77. PubMed ID: 22313101
[TBL] [Abstract][Full Text] [Related]
35. Drug misuse and diversion in adults prescribed anxiolytics and sedatives.
McLarnon ME; Monaghan TL; Stewart SH; Barrett SP
Pharmacotherapy; 2011 Mar; 31(3):262-72. PubMed ID: 21361736
[TBL] [Abstract][Full Text] [Related]
36. Addressing OxyContin abuse.
FDA Consum; 2001; 35(4):3. PubMed ID: 11692884
[No Abstract] [Full Text] [Related]
37. Prescription drug abuse among prisoners in rural Southwestern Virginia.
Wunsch MJ; Nakamoto K; Goswami A; Schnoll SH
J Addict Dis; 2007; 26(4):15-22. PubMed ID: 18032228
[TBL] [Abstract][Full Text] [Related]
38. Internet-based survey of nonmedical prescription opioid use in the United States.
Katz N; Fernandez K; Chang A; Benoit C; Butler SF
Clin J Pain; 2008; 24(6):528-35. PubMed ID: 18574362
[TBL] [Abstract][Full Text] [Related]
39. New formulation of methadone for opioid dependence in France: acceptability and diversion/misuse liability.
Eiden C; Léglise Y; Bertomeu L; Clavel V; Faillie JL; Petit P; Peyrière H
Therapie; 2013; 68(2):107-11. PubMed ID: 23773351
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the resistance of a geopolymer-based drug delivery system to tampering.
Cai B; Engqvist H; Bredenberg S
Int J Pharm; 2014 Apr; 465(1-2):169-74. PubMed ID: 24556174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
